Insulin-like growth factor II as antitumour agent
US5902788A · kind A · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 1996 |
| Grant date | May 11, 1999 |
| Priority date | — |
| Expiry date | May 15, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of IGF-II for the manufacture of a medicament for the treatment of tumours, and especially for the manufacture of a medicament for growth inhibition of melanoma cells and for the treatment of cutaneous melanomas. The medicament can be systemically or locally administered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.